Samrat Pharmachem share news, announcements and annual reports
BSE: 530125Pharmaceuticals & BiotechnologySmall Cap
Samrat Pharmachem Ltd. · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹261.10down ₹10.25 (3.78%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹271.35.
30 Oct: open ₹272.00, high ₹272.00, low ₹261.00
52-week range of traded prices to 30 Oct 2026
₹190.00Low, 30 Mar 2026₹309.85High, 30 Oct 2025
- Under BSE's long-term additional surveillance, stage I, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Next results date: the board meets on 14 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹81 Cr3,210th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.18
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- −3.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −2.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.16
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 683
Samrat Pharmachem board meetings
92 filed, newest first. Page 2 of 2.
Apr 2022
7 Apr · Board meeting
Meeting on 30 May 2022: audited results and dividend
Dec 2021
28 Dec · Board meeting
Meeting on 10 Feb 2022: quarterly results
Nov 2021
Sep 2021
28 Sep · Board meeting
Meeting on 13 Nov 2021: quarterly results
Aug 2021
Jul 2021
6 Jul · Board meeting
Meeting on 13 Aug 2021: quarterly results
Jun 2021
7 Jun · Board meeting
Meeting on 30 Jun 2021: audited results
Feb 2021
Jan 2021
13 Jan · Board meeting
Meeting on 13 Feb 2021: quarterly results
Oct 2020
20 Oct · Board meeting
Meeting on 13 Nov 2020: quarterly results
Aug 2020
31 Aug · Board meeting
Meeting on 14 Sep 2020: quarterly results
Jul 2020
15 Jul · Board meeting
Meeting on 31 Jul 2020: audited results
Feb 2020
Dec 2019
31 Dec · Board meeting
Meeting on 14 Feb 2020: quarterly results
Nov 2019
Sep 2019
30 Sep · Board meeting
Meeting on 14 Nov 2019: quarterly results
Aug 2019
Jul 2019
9 Jul · Board meeting
Meeting on 14 Aug 2019: quarterly results
May 2019
Apr 2019
9 Apr · Board meeting
Meeting on 30 May 2019: audited results
Feb 2019
Jan 2019
7 Jan · Board meeting
Meeting on 14 Feb 2019: quarterly results
Nov 2018
Oct 2018
Oct 2016
Jul 2016
6 Jul · Board meeting
Meeting of the Board of Directors of the Company will be held on August 12, 2016, to consider, approve and take on record the Un-Audited Financial ....